
Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its evolution into a global organization and forming part of Inizio Advisory. Her outstanding contributions to the company’s growth and expansion has led to her well-earned appointment to this new position. Angela will now spearhead the strategic growth of our European teams, ensuring our clients receive high quality insights and solutions to their business challenges.
In addition, Grzegorz Stanczyk has joined Research Partnership as Operations Director, having previously worked at Hall and Partners. With a wealth of experience in operational strategy within the market research industry, Grzegorz will play a pivotal role in supporting our ad-hoc research teams and overseeing our Compliance and Commercial Affairs functions. His expertise in client and supplier contracting, as well as MSA negotiations, will help to enhance our operations.
Helen Cox has joined the business as Senior Commercial Director. Helen is an accomplished insights professional with over 25 years’ experience, having led client engagement across healthcare clients in her most recent role at Ipsos, both in defining the overall strategy and leading client accounts. Helen brings a wealth of experience in strengthening client partnerships, understanding clients’ businesses, and bringing the very best expertise to every engagement, which will help to strengthen our commercial strategy at Research Partnership.
CEO of Research Partnership, Gareth Phillips, commented “I am delighted to congratulate Angela on her new appointment and welcome Grzegorz and Helen to the team. Angela’s expertise will be instrumental in delivering enhanced value to our clients within the European sector. Grzegorz and Helen both bring a wealth of knowledge and fresh perspectives to our dynamic workforce, and I look forward to collaborating with them both as we strengthen our Operational and Commercial capabilities across our global teams.”
Find out more and explore a range of resources at Research Partnership.
This content was provided by Inizio
Latest Content from Inizio
Evolution from man to machine
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio…
Despite the global advances made in the treatment for asthma, many studies have shown that asthma remains uncontrolled for a large proportion of patients, when assessed according to international guidelines….
Organising a company’s presence, not just logistically, but in terms of delivering key information, data and messages, is a massive part of some people’s workload at this time of year….
Two clients were co-developing a product and needed to understand the patient journey in two areas of oncology, in order to identify the leverage points where they could provide an…
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?
As part of our continued growth, we are delighted to announce a new intake of 17 Research Analysts and 5 Fieldwork Project Coordinators into our annual market research graduate programme.http://www.researchpartnership.com/news/2016/09/new-graduates-2016/
With the imminent expected approval and launch of a new product, our client needed to conduct global tracking research to understand knowledge, perceptions, awareness and recall around their product and the quality…
The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by…
The IBD syndicated market tracker is part of our large auto-immune portfolio
